- Contractors
- Organotherapeutics Gmbh
Organotherapeutics Gmbh
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Organotherapeutics Gmbh has 1 federal contract of $100,000 or more active since October 2023, with $254K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.
- Contracts
- 1 since FY2024$253,868 obligated, contracts of $100,000 or more
- Running now
- 1 contract
- Biggest customer
- Food and Drug Administration$254K on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- KY6GHXV1CLK3Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Eo 14398 Human Hindbrain OrganoidsFood and Drug Administration · 75F40126P00334 | $253,868 | Mar 29, 2028in 16 months | Not stated |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Food and Drug Administration1 contract | $253,868 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $253,868 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.
Get new notices like Organotherapeutics Gmbh's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy